Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylorieradication
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylorieradication ; volume:9 ; number:1 ; day:26 ; month:5 ; year:2009 ; pages:1-5 ; date:12.2009
BMC gastroenterology ; 9, Heft 1 (26.5.2009), 1-5, 12.2009
- Creator
-
Eisig, Jaime N.
- Contributor
-
Silva, Fernando M.
Barbuti, Ricardo C.
Rodriguez, Tomás Navarro
Malfertheiner, Peter
Filho, Moraes Joaquim PP
Zaterka, Schlioma
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-9-38
- URN
-
urn:nbn:de:1111-2016081211992
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eisig, Jaime N.
- Silva, Fernando M.
- Barbuti, Ricardo C.
- Rodriguez, Tomás Navarro
- Malfertheiner, Peter
- Filho, Moraes Joaquim PP
- Zaterka, Schlioma
- SpringerLink (Online service)
Other Objects (12)
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
Esomeprazol-Levofloxacin-Amoxicillin-Tripel-Therapie der Helicobacter-pylori-Infektion bei bekannter Sensitivität von Helicobacter pylori
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
Present-day English, [...]. Basic course, main course.
Present-day English, [...]. Basic course, main course
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
Esomeprazol-Levofloxacin-Amoxicillin-Tripel-Therapie der Helicobacter-pylori-Infektion bei bekannter Sensitivität von Helicobacter pylori
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
Present-day English, [...]. Basic course, main course.
Present-day English, [...]. Basic course, main course
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin
Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
Esomeprazol-Levofloxacin-Amoxicillin-Tripel-Therapie der Helicobacter-pylori-Infektion bei bekannter Sensitivität von Helicobacter pylori
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter Pylori infection in Syrian population single-center experience
Present-day English, [...]. Basic course, main course.
Present-day English, [...]. Basic course, main course
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen
Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin